On the 24th of July 2015, the COREX team successfully passed a difficult exam – a third-party inspection performed on behalf of COREX`s key sponsor by the TÜV Rheinland Group in compliance with the international labor protection requirements and Pharmaceutical Supply Chain Initiative (PSCI) principles.

About TUV Rheinland

The TÜV Rheinland Group is an internationally recognized leading provider of technical and auditing services worldwide. Since it was founded in 1872 TÜV Rheinland has developed from a regional testing agency to a leading international provider of inspection services. See more via:

Scope of Audit

Environmental, health, and safety management system (EHS management system); Supplier management; Environmental protection; Labor and Ethics management; Quality management.


The auditors reported the absence of critical, major and minor findings. Moreover, two best-practices in HR and Labor protection were pointed out. That means that COREX fully complied with and exceeds local and international regulations and standards.

In this context, our compliance management system forms the foundation of our corporate sustainability practice. Compliance is the adherence to applicable laws and internal regulations and is of paramount importance for the clinical trial industry.

Sustainability is a core principle for us and determines our actions. We work profit-oriented with respect to our social and environmental responsibility. We understand the responsibility we have as a company for people, society, and the environment. We are committed to making a contribution to a future that meets both human and environmental sustainable needs.

Our most valuable asset is the trust our customers invest in COREX and our excellent service standards. In this way, we contribute to creating a brighter future in which we can improve lives and protect the environment.

Vera Ostrovskaya, Quality Director

Back to the list

Industry insights

CPhI Worldwide 2018

COREX representatives will be attending CPhI Worldwide 2018.

Annual results 2019 of CT market: ACT...

The Association of Clinical Trials Organizations (ACTO) (Russia) recently published an overview of clinical trials market in 2019.

Clinical trials and delivery in post-...

The pharmaceutical industry has faced numerous challenges since the beginning of 2021 including the rush to supply COVID-19 vaccines. The start of the year also saw the departure of the UK from the EU and theEuropean Medicines Agency (EMA). The Medicines and Healthcare Products Regulatory Agency (MHRA) is now fully in charge of all regulatory matters, oversight of clinical research and approval of medicines.


We’re here to help.
Email us at or use our feedback form to send us your question.

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read More.